TY - JOUR
T1 - Trajectories of post-traumatic stress symptoms, anxiety, and depression in hospitalized COVID-19 patients
T2 - A one-month follow-up
AU - Matalon, Noam
AU - Dorman-Ilan, Shirel
AU - Hasson-Ohayon, Ilanit
AU - Hertz-Palmor, Nimrod
AU - Shani, Shachar
AU - Basel, Dana
AU - Gross, Raz
AU - Chen, Wendy
AU - Abramovich, Ayelet
AU - Afek, Arnon
AU - Ziv, Amitai
AU - Kreiss, Yitshak
AU - Pessach, Itai M.
AU - Gothelf, Doron
N1 - Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/4
Y1 - 2021/4
N2 - Objectives: Little is known about the mental health outcomes of hospitalized COVID-19 patients. The aims of the study were: (1) to examine the trajectories of anxiety, depression, and pandemic-related stress factors (PRSF) of COVID-19 hospitalized patients one-month following hospitalization; (2) to assess the presence of post-traumatic stress symptoms (PTSS) a month after hospitalization; (3) to identify baseline risk and protective factors that would predict PTSS one month after hospitalization. Methods: We contacted hospitalized COVID-19 patients (n = 64) by phone, at three time-points: during the first days after admission to the hospital (T1); after ~two weeks from the beginning of hospitalization (T2), and one month after hospitalization (T3). At all time-points we assessed the levels of anxiety and depression symptoms, as well as PRSF. At T3, PTSS were assessed. Results: The levels of depressive and anxiety symptoms decreased one-month following hospitalization. Moreover, higher levels of anxiety (standardized β = 1.15, 95% CI = 0.81–1.49, p < 0.001) and depression (β = 0.97, 95% CI = 0.63–1.31 p < 0.001) symptoms during the first week of hospitalization, feeling socially disconnected (β = 0.59, 95% CI = 0.37–0.81 p < 0.001) and experiencing a longer hospitalization period (β = 0.25, 95% CI = 0.03–0.47 p = 0.026) predicted higher PTSS scores a month post-hospitalization. Conclusions: We identified early hospitalization risk factors for the development of PTSS one month after hospitalization that should be targeted to reduce the risk for PTSS.
AB - Objectives: Little is known about the mental health outcomes of hospitalized COVID-19 patients. The aims of the study were: (1) to examine the trajectories of anxiety, depression, and pandemic-related stress factors (PRSF) of COVID-19 hospitalized patients one-month following hospitalization; (2) to assess the presence of post-traumatic stress symptoms (PTSS) a month after hospitalization; (3) to identify baseline risk and protective factors that would predict PTSS one month after hospitalization. Methods: We contacted hospitalized COVID-19 patients (n = 64) by phone, at three time-points: during the first days after admission to the hospital (T1); after ~two weeks from the beginning of hospitalization (T2), and one month after hospitalization (T3). At all time-points we assessed the levels of anxiety and depression symptoms, as well as PRSF. At T3, PTSS were assessed. Results: The levels of depressive and anxiety symptoms decreased one-month following hospitalization. Moreover, higher levels of anxiety (standardized β = 1.15, 95% CI = 0.81–1.49, p < 0.001) and depression (β = 0.97, 95% CI = 0.63–1.31 p < 0.001) symptoms during the first week of hospitalization, feeling socially disconnected (β = 0.59, 95% CI = 0.37–0.81 p < 0.001) and experiencing a longer hospitalization period (β = 0.25, 95% CI = 0.03–0.47 p = 0.026) predicted higher PTSS scores a month post-hospitalization. Conclusions: We identified early hospitalization risk factors for the development of PTSS one month after hospitalization that should be targeted to reduce the risk for PTSS.
KW - Anxiety
KW - COVID-19
KW - Depression
KW - Mental health
KW - PTSS
KW - Patients
UR - http://www.scopus.com/inward/record.url?scp=85101152381&partnerID=8YFLogxK
U2 - 10.1016/j.jpsychores.2021.110399
DO - 10.1016/j.jpsychores.2021.110399
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 33618149
AN - SCOPUS:85101152381
SN - 0022-3999
VL - 143
JO - Journal of Psychosomatic Research
JF - Journal of Psychosomatic Research
M1 - 110399
ER -